ASHWANI KUMAR AGARWAL
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine
- Where
- MIDLOTHIAN, TX
- NPI
- 1801837497
- Received
- $275,151 in 1,371 records, 2019 to 2025
- As principal investigator
- $2,650 of research payments to others in 1 record
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 178 | $18,233 |
| 2024 | General payment | 180 | $18,464 |
| 2023 | General payment | 189 | $36,056 |
| 2022 | General payment | 187 | $46,888 |
| 2021 | General payment | 156 | $27,199 |
| 2020 | General payment | 201 | $47,979 |
| 2019 | General payment | 280 | $80,329 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 65 | $137,218 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 23 | $44,355 |
| Honoraria | 20 | $37,118 |
| Food and Beverage | 1,148 | $29,450 |
| Travel and Lodging | 100 | $26,302 |
| Education | 15 | $707 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Aveo Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-12-29 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-12-22 | EMD Serono, Inc. | $36 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-12-19 | Incyte Corporation | $15 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-12-18 | Regeneron Healthcare Solutions, Inc. | $18 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-12-17 | Syndax Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-16 | Astellas Pharma US Inc | $26 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-12-12 | EMD Serono, Inc. | $28 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-12-10 | Astellas Pharma US Inc | $27 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-12-09 | Takeda Pharmaceuticals U.S.A., Inc. | $42 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-12-08 | Ipsen Biopharmaceuticals, Inc | $25 | Food and Beverage | In-kind items and services | Onivyde Drug, Oncology | 2025 | |
| 2025-12-03 | Merck Sharp & Dohme LLC | $19 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-12-03 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-12-03 | AstraZeneca Pharmaceuticals LP | $2 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-12-01 | Incyte Corporation | $22 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-11-24 | Regeneron Healthcare Solutions, Inc. | $32 | Food and Beverage | In-kind items and services | LYNOZYFIC Biological, HEMATOLOGY AND ONCOLOGY | 2025 | |
| 2025-11-21 | Genentech USA, Inc. | $24 | Food and Beverage | In-kind items and services | Tecentriq Biological, BioOncology | 2025 | |
| 2025-11-19 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-11-18 | E.R. Squibb & Sons, L.L.C. | $20 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-11-17 | Iovance Biotherapeutics, Inc. | $13 | Food and Beverage | Cash or cash equivalent | Amtagvi Drug, Oncology | 2025 | |
| 2025-11-12 | GlaxoSmithKline, LLC. | $123 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-11-11 | Gilead Sciences, Inc. | $20 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-11-10 | Takeda Pharmaceuticals U.S.A., Inc. | $43 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-11-10 | Janssen Biotech, Inc. | $11 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-11-06 | Daiichi Sankyo Inc. | $27 | Food and Beverage | In-kind items and services | DATROWAY Drug, ONCOLOGY | 2025 | |
| 2025-11-05 | RECORDATI_RARE_DISEASES_INC. | $23 | Food and Beverage | In-kind items and services | ENJAYMO Drug, HEMATOLOGY | 2025 | |
| 2025-11-05 | TAIHO ONCOLOGY, INC. | $19 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-11-04 | Merck Sharp & Dohme LLC | $22 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-11-03 | BeOne Medicines USA, Inc. | $17 | Food and Beverage | In-kind items and services | TEVIMBRA Drug, Oncology | 2025 | |
| 2025-10-30 | Merck Sharp & Dohme LLC | $19 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-10-29 | Caris MPI, Inc. | $14 | Food and Beverage | In-kind items and services | MI CANCER SEEK Device, ONCOLOGY | 2025 | |
| 2025-10-29 | Janssen Biotech, Inc. | $8 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-10-28 | PharmaEssentia USA Corporation | $31 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-10-21 | Sirtex Medical Inc | $10 | Food and Beverage | Cash or cash equivalent | SIR-Spheres Microspheres Device, Interventional Oncology | 2025 | |
| 2025-10-20 | ARRAY BIOPHARMA INC | $16 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-10-08 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-10-06 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-10-06 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-10-06 | Ipsen Biopharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | Onivyde Drug, Oncology | 2025 | |
| 2025-10-01 | Astellas Pharma US Inc | $19 | Food and Beverage | In-kind items and services | Xtandi Drug, Oncology | 2025 | |
| 2025-09-29 | Rigel Pharmaceuticals, Inc. | $17 | Food and Beverage | Cash or cash equivalent | TAVALISSE Drug, Hematology | 2025 | |
| 2025-09-25 | Astellas Pharma US Inc | $108 | Food and Beverage | In-kind items and services | Xtandi Drug, Oncology | 2025 | |
| 2025-09-25 | Janssen Biotech, Inc. | $17 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-09-25 | Janssen Biotech, Inc. | $9 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-09-24 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-09-23 | Celgene Corporation | $34 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-09-23 | BeOne Medicines USA, Inc. | $14 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-09-22 | Eisai Inc. | $25 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-09-18 | E.R. Squibb & Sons, L.L.C. | $2,300 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-11 | Gilead Sciences, Inc. | $26 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-09-10 | PharmaEssentia USA Corporation | $33 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-09-10 | Eisai Inc. | $26 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-09-08 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | EMRELIS Drug, ONCOLOGY | 2025 | |
| 2025-09-06 | Celgene Corporation | $60 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-09-06 | Celgene Corporation | $25 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-09-03 | ARRAY BIOPHARMA INC | $17 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-09-03 | PUMA BIOTECHNOLOGY, INC. | $15 | Food and Beverage | In-kind items and services | NERLYNX Drug, ONCOLOGY | 2025 | |
| 2025-09-02 | Gilead Sciences, Inc. | $25 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-08-28 | GENZYME CORPORATION | $25 | Food and Beverage | In-kind items and services | CABLIVI Biological, Hematology | 2025 | |
| 2025-08-27 | Exelixis Inc. | $19 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-08-26 | TAIHO ONCOLOGY, INC. | $24 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-08-25 | SOBI, INC | $32 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2025-08-20 | Genentech USA, Inc. | $25 | Food and Beverage | In-kind items and services | Itovebi Biological, BioOncology | 2025 | |
| 2025-08-20 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-08-19 | PFIZER INC. | $21 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-08-18 | Alexion Pharmaceuticals, Inc. | $33 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2025 | |
| 2025-08-14 | JAZZ PHARMACEUTICALS INC. | $26 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-08-13 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-08-13 | PFIZER INC. | $5 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-08-12 | Janssen Biotech, Inc. | $32 | Food and Beverage | In-kind items and services | CARVYKTI Drug, Oncology | 2025 | |
| 2025-08-11 | Novartis Pharmaceuticals Corporation | $12 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-08-04 | Incyte Corporation | $22 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-07-31 | Incyte Corporation | $124 | Food and Beverage | Cash or cash equivalent | Zynyz Drug, Oncology | 2025 | |
| 2025-07-31 | Gilead Sciences, Inc. | $24 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-07-30 | Novartis Pharmaceuticals Corporation | $34 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-07-30 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-07-28 | Iovance Biotherapeutics, Inc. | $23 | Food and Beverage | Cash or cash equivalent | Amtagvi Drug, Oncology | 2025 | |
| 2025-07-28 | GENZYME CORPORATION | $22 | Food and Beverage | In-kind items and services | CABLIVI Biological, Hematology | 2025 | |
| 2025-07-24 | Janssen Biotech, Inc. | $150 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-07-23 | Janssen Biotech, Inc. | $41 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-07-23 | Takeda Pharmaceuticals U.S.A., Inc. | $25 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-07-21 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $25 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-07-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-15 | Sirtex Medical Inc | $18 | Food and Beverage | Cash or cash equivalent | SIR-Spheres Microspheres Device, Interventional Oncology | 2025 | |
| 2025-07-14 | Janssen Biotech, Inc. | $22 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-07-14 | Janssen Biotech, Inc. | $1 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-07-02 | Genmab U.S., Inc. | $27 | Food and Beverage | In-kind items and services | Tivdak Drug, Oncology | 2025 | |
| 2025-06-30 | Merck Sharp & Dohme LLC | $29 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-06-25 | Immunocore Limited | $22 | Food and Beverage | In-kind items and services | KIMMTRAK Drug, Oncology | 2025 | |
| 2025-06-25 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-06-24 | PharmaEssentia USA Corporation | $33 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-06-24 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-06-23 | Blueprint Medicines Corporation | $25 | Food and Beverage | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2025 | |
| 2025-06-23 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-06-18 | Tempus AI, Inc | $27 | Food and Beverage | In-kind items and services | XT CDX Device, ONCOLOGY | 2025 | |
| 2025-06-17 | Bayer Healthcare Pharmaceuticals Inc. | $23 | Food and Beverage | In-kind items and services | Stivarga Drug, Oncology | 2025 | |
| 2025-06-16 | ARRAY BIOPHARMA INC | $21 | Food and Beverage | In-kind items and services | XALKORI Drug, ONCOLOGY | 2025 | |
| 2025-06-13 | Janssen Biotech, Inc. | $1,010 | Consulting Fee | Cash or cash equivalent | ERLEADA Drug, Oncology | 2025 | |
| 2025-06-12 | SpringWorks Therapeutics, Inc. | $22 | Food and Beverage | In-kind items and services | OGSIVEO Drug, DESMOID TUMORS | 2025 | |
| 2025-06-12 | Janssen Biotech, Inc. | $8 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-06-11 | GlaxoSmithKline, LLC. | $26 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-06-04 | Kite Pharma, Inc. | $24 | Food and Beverage | In-kind items and services | Yescarta Drug, CELLT | 2025 | |
| 2025-06-03 | SOBI, INC | $24 | Food and Beverage | In-kind items and services | Doptelet Drug, Hematology/Oncology | 2025 | |
| 2025-06-03 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-06-02 | PFIZER INC. | $31 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-05-29 | Incyte Corporation | $17 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-05-21 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | EMRELIS Drug, ONCOLOGY | 2025 | |
| 2025-05-20 | Incyte Corporation | $29 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-05-20 | Incyte Corporation | $20 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-05-19 | Merck Sharp & Dohme LLC | $31 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-05-19 | Daiichi Sankyo Inc. | $23 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-05-16 | Merck Sharp & Dohme LLC | $3,960 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-05-16 | Merck Sharp & Dohme LLC | $150 | Travel and Lodging | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-05-15 | Bayer Healthcare Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-05-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-13 | Gilead Sciences, Inc. | $24 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-05-08 | Merck Sharp & Dohme LLC | $1,174 | Travel and Lodging | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-05-08 | Merck Sharp & Dohme LLC | $115 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-05-08 | Gilead Sciences, Inc. | $23 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-05-08 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-04-30 | Syndax Pharmaceuticals, Inc. | $122 | Food and Beverage | In-kind items and services | REVUFORJ Drug, HEMATOLOGY-ONCOLOGY | 2025 | |
| 2025-04-30 | Blueprint Medicines Corporation | $23 | Food and Beverage | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2025 | |
| 2025-04-28 | Regeneron Healthcare Solutions, Inc. | $33 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-04-28 | Janssen Biotech, Inc. | $11 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-04-23 | PFIZER INC. | $29 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-04-22 | Incyte Corporation | $124 | Food and Beverage | Cash or cash equivalent | Jakafi Drug, Hematology/Oncology | 2025 | |
| 2025-04-22 | E.R. Squibb & Sons, L.L.C. | $28 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-04-22 | Janssen Biotech, Inc. | $22 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-04-21 | AstraZeneca Pharmaceuticals LP | $27 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-04-16 | SOBI, INC | $28 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2025-04-15 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-04-11 | Novocure Inc. | $55 | Food and Beverage | Cash or cash equivalent | Optune Lua (NovoTTF-200T) Device, Oncology | 2025 | |
| 2025-04-09 | Geron Corporation | $24 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-04-07 | Karyopharm Therapeutics Inc. | $24 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-04-03 | Karyopharm Therapeutics Inc. | $190 | Honoraria | Cash or cash equivalent | XPOVIO Drug, Oncology | 2025 | |
| 2025-04-03 | Karyopharm Therapeutics Inc. | $14 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-04-02 | Janssen Biotech, Inc. | $23 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-03-31 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-03-31 | BeOne Medicines USA, Inc. | $17 | Food and Beverage | In-kind items and services | TEVIMBRA Drug, Oncology | 2025 | |
| 2025-03-26 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2025 | |
| 2025-03-25 | Sirtex Medical Inc | $15 | Food and Beverage | Cash or cash equivalent | SIR-Spheres Microspheres Device, Interventional Oncology | 2025 | |
| 2025-03-25 | GENZYME CORPORATION | $13 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-19 | SOBI, INC | $29 | Food and Beverage | In-kind items and services | Doptelet Drug, Hematology/Oncology | 2025 | |
| 2025-03-18 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-03-17 | Eisai Inc. | $25 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-03-11 | TAIHO ONCOLOGY, INC. | $28 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-03-05 | Deciphera Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | QINLOCK Drug, ONCOLOGY | 2025 | |
| 2025-03-05 | Sirtex Medical Inc | $9 | Food and Beverage | Cash or cash equivalent | SIR-Spheres Microspheres Device, Interventional Oncology | 2025 | |
| 2025-03-03 | AstraZeneca Pharmaceuticals LP | $2,475 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-02-26 | Exelixis Inc. | $16 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-02-24 | PUMA BIOTECHNOLOGY, INC. | $18 | Food and Beverage | In-kind items and services | NERLYNX Drug, ONCOLOGY | 2025 | |
| 2025-02-24 | Janssen Biotech, Inc. | $12 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-02-20 | GlaxoSmithKline, LLC. | $15 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-02-17 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-02-14 | Exelixis Inc. | $1,975 | Honoraria | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-02-13 | Kite Pharma, Inc. | $22 | Food and Beverage | In-kind items and services | Yescarta Drug, CELLT | 2025 | |
| 2025-02-10 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | VYNDAQEL Drug, CARDIOVASCULAR | 2025 | |
| 2025-02-10 | ARRAY BIOPHARMA INC | $11 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-02-08 | Exelixis Inc. | $343 | Travel and Lodging | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-02-08 | Exelixis Inc. | $115 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-02-08 | Exelixis Inc. | $65 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-02-08 | Exelixis Inc. | $39 | Travel and Lodging | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-02-08 | Exelixis Inc. | $28 | Travel and Lodging | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-02-08 | Exelixis Inc. | $10 | Food and Beverage | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-02-08 | Exelixis Inc. | $5 | Food and Beverage | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-02-05 | PFIZER INC. | $26 | Food and Beverage | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2025 | |
| 2025-01-29 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-01-28 | E.R. Squibb & Sons, L.L.C. | $23 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-01-27 | Novartis Pharmaceuticals Corporation | $8 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-01-22 | Merck Sharp & Dohme LLC | $19 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-01-22 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-01-21 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-01-16 | AstraZeneca Pharmaceuticals LP | $28 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-16 | Azurity Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | DANZITEN Drug, ONCOLOGY | 2025 | |
| 2025-01-15 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-01-13 | Apellis Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Empaveli Drug, Hematology | 2025 | |
| 2025-01-08 | Novartis Pharmaceuticals Corporation | $34 | Food and Beverage | In-kind items and services | LUTATHERA Drug, Oncology | 2025 | |
| 2024-12-16 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2024 | |
| 2024-12-12 | AstraZeneca Pharmaceuticals LP | $525 | Consulting Fee | Cash or cash equivalent | Truqap Drug, Oncology | 2024 | |
| 2024-12-12 | Janssen Biotech, Inc. | $23 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2024 | |
| 2024-12-11 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2024 | |
| 2024-12-09 | Karyopharm Therapeutics Inc. | $22 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2024 | |
| 2024-12-04 | Bayer Healthcare Pharmaceuticals Inc. | $2,622 | Consulting Fee | Cash or cash equivalent | Nubeqa Drug, Oncology | 2024 | |
| 2024-12-04 | Geron Corporation | $1,300 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-12-04 | Bayer Healthcare Pharmaceuticals Inc. | $77 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2024 | |
| 2024-12-04 | Bayer Healthcare Pharmaceuticals Inc. | $30 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2024 | |
| 2024-12-04 | Bayer Healthcare Pharmaceuticals Inc. | $12 | Travel and Lodging | In-kind items and services | Nubeqa Drug, Oncology | 2024 | |
| 2024-11-21 | Bayer Healthcare Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2024 | |
| 2024-11-20 | Tempus AI, Inc | $16 | Food and Beverage | In-kind items and services | XT CDX Device, NONE | 2024 | |
| 2024-11-19 | Mirati Therapeutics, Inc. | $23 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-11-18 | Novocure Inc. | $15 | Food and Beverage | Cash or cash equivalent | Optune Lua (NovoTTF-200T) Device, Oncology | 2024 | |
| 2024-11-15 | Rigel Pharmaceuticals, Inc. | $38 | Food and Beverage | Cash or cash equivalent | Rezlidhia Drug, Acute Myeloid Leukemia | 2024 | |
| 2024-11-14 | Tempus AI, Inc | $23 | Food and Beverage | In-kind items and services | XT CDX Device, NONE | 2024 | |
| 2024-11-13 | Boehringer Ingelheim Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | GILOTRIF Drug, ONCOLOGY | 2024 | |
| 2024-11-12 | TAIHO ONCOLOGY, INC. | $14 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2024 | |
| 2024-11-07 | GlaxoSmithKline, LLC. | $13 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2024 | |
| 2024-11-06 | Sirtex Medical Inc | $19 | Food and Beverage | Cash or cash equivalent | SIR-Spheres Microspheres Device, Interventional Oncology | 2024 | |
| 2024-11-05 | Takeda Pharmaceuticals U.S.A., Inc. | $16 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2024 | |
| 2024-11-04 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | IMJUDO Biological, Oncology | 2024 |
The latest 200 records of 1,371.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2021-12-31 | Merck Sharp & Dohme LLC | TEXAS ONCOLOGY METHODIST DALLAS CANCER CENTER | $2,650 | A Phase 3, Randomized, Double-Blind Study of Pembrolizumab plus Ipilimumab vs Pembrolizumab plus Placebo in Previously U | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Midlothian, TX, county Ellis County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Midlothian, TX | County Ellis County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 39,356 | 213,160 | 30,188,424 |
| Population, 2020 census P1 | 35,125 | 192,455 | 29,145,505 |
| Median age B01002 | 36.7 | 36.3 | 35.6 |
| Under 18 B01001 | 28.9% | 26.4% | 25.0% |
| 65 and over B01001 | 12.4% | 13.0% | 13.4% |
| Households B11001 | 13,024 | 71,759 | 10,992,816 |
| Foreign born B05002 | 6.0% | 8.5% | 17.6% |
| Median household income B19013 | $126,641 | $99,595 | $78,476 |
| Median family income B19113 | $133,742 | $110,734 | $94,599 |
| Per capita income B19301 | $47,287 | $40,925 | $40,752 |
| Poverty rate B17001 | 5.2% | 6.9% | 13.8% |
| Unemployment rate B23025 | 3.9% | 4.5% | 5.3% |
| Civilian labor force B23025 | 20,635 | 111,446 | 15,233,563 |
| Mean commute (minutes) B08013 | 31.7 | 30.3 | 26.7 |
| Bachelor's degree or higher B15003 | 35.8% | 30.1% | 33.8% |
| Housing units B25001 | 13,373 | 75,422 | 12,128,515 |
| Owner-occupied B25003 | 79.7% | 75.8% | 62.6% |
| Renters B25003 | 20.3% | 24.2% | 37.4% |
| Median home value B25077 | $411,800 | $348,600 | $283,800 |
| Median gross rent B25064 | $2,013 | $1,594 | $1,403 |
| White, not Hispanic B03002 | 64.9% | 52.7% | 39.1% |
| Black B03002 | 11.3% | 14.4% | 11.9% |
| Hispanic or Latino B03002 | 18.7% | 28.2% | 39.7% |
| Asian B03002 | 0.5% | 0.8% | 5.5% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Midlothian, TX.
Comments